LACTOSE (INDIA) LTD.

Lactose India Ltd has announced the closure of its trading window for designated persons and their immediate relatives. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct. The trading window will be shut from July 1, 2026, and will reopen 48 hours after the declaration of the financial results for the first quarter ended June 30, 2026. All concerned individuals are advised against trading in the company's securities during this period. The date for the board meeting to approve these results will be communicated separately.

Lactose India Ltd announced the forfeiture of 15,00,000 convertible warrants that were allotted on a preferential basis. The warrant holders failed to exercise their right to subscribe to equity shares by the June 5, 2026 deadline. Consequently, the company has forfeited the initial consideration of ₹6,52,50,000 received from the allottees, M/s. SG General Dealers LLP. The warrants were issued at a conversion price of ₹174 per warrant.

Lactose India Ltd has announced a Board of Directors meeting scheduled for June 18, 2026. The primary agenda item is to consider the forfeiture of 15,00,000 convertible share warrants allotted on a preferential basis to M/s. SG General Dealers LLP. This action is due to the non-payment of the balance consideration required for conversion into equity shares within the stipulated period. The meeting will also address any other business with the chair's permission.

Lactose India Ltd has released its audited financial results for the fourth quarter and financial year ended March 31, 2026. The results, along with the Independent Auditor's Report, have been submitted to the BSE as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The auditor's report states that the financial results present a true and fair view in accordance with Indian Accounting Standards.

Lactose India Ltd has scheduled a Board of Directors meeting on May 20, 2026, to consider and approve the audited financial results for the fourth quarter and financial year ended March 31, 2026. The trading window for dealing in the company's securities has been closed since April 1, 2026, and will reopen 48 hours after the declaration of the audited financial results.

Lactose India Ltd responded to BSE's query regarding a significant price movement in its security. The company clarified that there is no pending information or announcement under SEBI (LODR) Regulation, 2015, that could be attributed to the price fluctuation. They stated that the movement is purely due to market conditions, over which the company has no control or specific knowledge of the underlying reasons. Lactose India reaffirmed its commitment to timely disclosure of all required information to the stock exchanges.

Lactose India Ltd has announced the approval of a special resolution for a scheme of amalgamation between Vitanosh Ingredients Private Limited and Lactose (India) Limited. The resolution was approved during the Extra Ordinary General Meeting held on 28th March 2026. The meeting was conducted through Video Conference / Other Audio Video Means, and shareholders were provided with remote e-voting and e-voting facilities. The scrutinizer, Adv. Arjun Lakhanpal, oversaw the voting process to ensure fairness and transparency. All resolutions were approved by the shareholders with the requisite majority.

Lactose India Ltd has announced the closure of the trading window for the fourth quarter and year ended 31st March 2026. The trading window will remain closed from 1st April 2026 and will reopen after 48 hours of the declaration of audited financial results. The board meeting for the consideration of the audited financial results will be intimated in due course. All concerned persons are advised not to deal in securities of Lactose (India) Limited during the said prohibited period.

Lactose India Ltd. has issued a corrigendum to the notice of the Extraordinary General Meeting (EGM) of the Company, scheduled to be held on Saturday, 28th March, 2026. The corrigendum provides modifications/clarifications to the resolutions and/or explanatory statement contained in the original notice. The EGM is being held in compliance with the NCLT order and will be conducted through Video Conferencing / Other Audio Visual Means. The corrigendum includes the shareholding pattern of Promoter/Promoter Group and Public shareholders before and after the implementation of the scheme, and the impact of the scheme on the public shareholders.

Lactose India Ltd has reported its financial results for the quarter and nine months ended 31st December 2025. The company's profit before tax stands at INR 6,051.28 million. The results have been reviewed by the Audit Committee and approved by the Board of Directors. The company operates in the pharmaceuticals sector and is in the process of merging with Vitanosh Ingredients Private Limited, pending regulatory approvals.